GO:0032730 positive regulation of interleukin-1 alpha production: Cytokine Secretion Pathway, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0032730 describes any process that activates or increases the frequency, rate, or extent of interleukin-1 alpha (IL-1 alpha) production.
IL-1 alpha is a pleiotropic cytokine that can be secreted via unconventional autophagy-based pathways, particularly in keratinocytes during psoriatic inflammation.
Intracellular IL-1 alpha in peritumoral monocytes can induce IL8 production and inhibit mitophagy, promoting stemness and metastasis in hepatocellular carcinoma.
IL-1 alpha acts as a paracrine factor in the testis, regulating Leydig cell function and steroidogenesis.
IL-1 alpha induces secondary cytokines such as GM-CSF in bone marrow cells and hepatocyte growth factor in skin fibroblasts, amplifying inflammatory networks [4,8].
CRISPR-based models (knockout, knock-in, overexpression) are essential to dissect the causal roles of genes regulating IL-1 alpha production in disease [1,3].

Description

Interleukin-1 alpha (IL-1 alpha) is a potent pro-inflammatory cytokine that plays a central role in innate immunity and tissue homeostasis. The Gene Ontology term GO:0032730, positive regulation of interleukin-1 alpha production, encompasses any biological process that activates or increases the frequency, rate, or extent of IL-1 alpha production. This includes transcriptional upregulation, post-translational processing, and unconventional secretion mechanisms. Understanding this process is critical because dysregulated IL-1 alpha production is implicated in chronic inflammatory diseases, cancer progression, and autoimmune conditions [1,3]. Recent studies have revealed that IL-1 alpha can be secreted through autophagy-based unconventional pathways, particularly in keratinocytes, where it drives psoriatic skin inflammation. Moreover, intracellular IL-1 alpha in peritumoral monocytes promotes hepatocellular carcinoma stemness and metastasis by inducing IL8 and inhibiting mitophagy. These findings highlight the importance of precise regulation of IL-1 alpha production in both physiological and pathological contexts. Researchers studying GO:0032730 aim to identify the molecular players and signaling cascades that control IL-1 alpha levels, with the ultimate goal of developing targeted therapies for inflammatory diseases and cancer.

positive regulation of interleukin-1 alpha production At A Glance

GO ID GO:0032730
GO term positive regulation of interleukin-1 alpha production
Ontology biological_process
Synonym activation of interleukin-1 alpha production; positive regulation of IL-1 alpha production; positive regulation of interleukin-1 alpha biosynthetic process; positive regulation of interleukin-1 alpha secretion; stimulation of interleukin-1 alpha production; up regulation of interleukin-1 alpha production; up-regulation of interleukin-1 alpha production; upregulation of interleukin-1 alpha production
Major function Increases the frequency, rate, or extent of IL-1 alpha production, a key pro-inflammatory cytokine.
Related processes Inflammatory response, cytokine secretion, autophagy-based unconventional secretion, immune cell activation.
Cellular context Keratinocytes, monocytes, macrophages, fibroblasts, bone marrow cells, testicular cells.
Disease relevance Psoriasis, hepatocellular carcinoma, acute myeloblastic leukemia, pancreatic carcinoma, inflammatory disorders.

What Is GO:0032730?

GO:0032730 is defined as any process that activates or increases the frequency, rate, or extent of interleukin-1 alpha production. This includes positive regulation of IL-1 alpha biosynthetic process and secretion, as well as stimulation or upregulation of its production.

Why Is positive regulation of interleukin-1 alpha production Important in Cell Biology?

GO:0032730 is critically important because IL-1 alpha is a master regulator of inflammation and immunity, and its overproduction contributes to a wide range of diseases, including psoriasis, cancer, and autoimmune disorders [1,3]. Understanding the positive regulation of IL-1 alpha production provides insights into how inflammatory responses are initiated and sustained, and identifies potential therapeutic targets for modulating these processes.
IL-1 alpha is a key mediator of psoriatic skin inflammation, secreted by keratinocytes via autophagy-based unconventional pathways.
Intracellular IL-1 alpha in peritumoral monocytes promotes hepatocellular carcinoma stemness and metastasis by inducing IL8 and inhibiting mitophagy.
IL-1 alpha acts as a paracrine factor in the testis, regulating Leydig cell steroidogenesis and testicular function.
IL-1 alpha induces GM-CSF in immature normal bone marrow cells, linking inflammation to hematopoiesis.
IL-1 alpha upregulates hepatocyte growth factor gene expression in human skin fibroblasts, contributing to tissue repair and fibrosis.
Pancreas-carcinoma-derived IL-1 alpha induces E-selectin expression, enhancing adhesion of carcinoma cells to endothelial cells and promoting metastasis.
IL-1 alpha affects blast cells of acute myeloblastic leukemia, influencing leukemic cell proliferation and survival.
IL-1 alpha regulates hyaluronate production in cultured human chorionic cells, impacting reproductive tissue remodeling.
Dysregulated IL-1 alpha production is implicated in chronic inflammatory diseases and autoimmune conditions, making it a therapeutic target [1,3].
CRISPR-based gene editing enables precise dissection of the regulatory networks controlling IL-1 alpha production [1,3].

What Happens During positive regulation of interleukin-1 alpha production?

Transcriptional Activation of IL1A
In simple terms: The cell receives a signal to make more IL-1 alpha, so it turns on the IL1A gene.
Positive regulation of IL-1 alpha production often begins with transcriptional activation of the IL1A gene in response to inflammatory stimuli. In keratinocytes, this can be triggered by damage-associated molecular patterns or cytokines, leading to increased IL1A mRNA levels. Similarly, in monocytes, intracellular IL-1 alpha expression is upregulated in peritumoral regions, contributing to hepatocellular carcinoma progression.
Post-translational Processing and Unconventional Secretion
In simple terms: After the protein is made, it can be packaged and released from the cell in an unusual way that does not use the standard secretion pathway.
IL-1 alpha lacks a signal peptide and is secreted via unconventional pathways. Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation, and similar mechanisms may regulate IL-1 alpha release. This process involves the formation of autophagosomes and their fusion with the plasma membrane, allowing secretion of IL-1 alpha without passing through the endoplasmic reticulum-Golgi route.
Paracrine and Autocrine Signaling
In simple terms: Once released, IL-1 alpha can act on nearby cells or the same cell to amplify the inflammatory response.
Secreted IL-1 alpha binds to IL-1 receptor type I (IL-1R1) on target cells, initiating signaling cascades that further enhance IL-1 alpha production. In the testis, IL-1 alpha acts as a paracrine factor regulating Leydig cell function. In pancreatic carcinoma, tumor-derived IL-1 alpha induces E-selectin expression on endothelial cells, promoting adhesion and metastasis.
Amplification via Secondary Cytokines
In simple terms: IL-1 alpha can stimulate the production of other cytokines, creating a positive feedback loop that increases inflammation.
IL-1 alpha induces the production of secondary cytokines such as GM-CSF in bone marrow cells and hepatocyte growth factor in skin fibroblasts. These secondary mediators can further stimulate IL-1 alpha production, establishing an amplification loop that sustains inflammatory responses [4,8].
Regulation by Intracellular IL-1 alpha in Cancer
In simple terms: Inside cancer-associated cells, IL-1 alpha can drive tumor growth and spread by affecting energy metabolism and stemness.
Intracellular IL-1 alpha in peritumoral monocytes induces IL8 production and inhibits mitophagy, promoting stemness and metastasis of hepatocellular carcinoma. This highlights a non-canonical role for IL-1 alpha in cancer biology, where its positive regulation contributes to tumor progression.

Key Genes Involved in GO:0032730 positive regulation of interleukin-1 alpha production

The following genes and proteins are involved in the positive regulation of interleukin-1 alpha production, based on published literature.
GeneMajor RoleResearch Relevance
IL1AEncodes interleukin-1 alpha, the cytokine whose production is positively regulated.Central to studies of GO:0032730; target for knockout and overexpression models [1,3].
HMGB1Autophagy-based unconventional secretion mediator in keratinocytes.Linked to psoriatic inflammation and IL-1 alpha secretion.
IL1R1Receptor for IL-1 alpha, mediates autocrine/paracrine signaling.Key for feedback regulation of IL-1 alpha production.
IL8Induced by intracellular IL-1 alpha in monocytes.Promotes stemness and metastasis in hepatocellular carcinoma.
CSF2GM-CSF, induced by IL-1 alpha in bone marrow cells.Links IL-1 alpha to hematopoiesis and inflammation.
HGFHepatocyte growth factor, upregulated by IL-1 in fibroblasts.Implicated in tissue repair and fibrosis.
SELEE-selectin, induced by pancreas-carcinoma-derived IL-1 alpha.Enhances adhesion of carcinoma cells to endothelium.
TNFTumor necrosis factor-alpha, can synergize with IL-1 in leukemia cells.Modulates blast cell responses in acute myeloblastic leukemia.
IFNA1Interferon-alpha, affects IL-1 signaling in leukemia cells.Studied in acute myeloblastic leukemia context.
ATG5Autophagy-related protein, involved in unconventional secretion.Potential regulator of IL-1 alpha release.
ATG7Autophagy-related protein, required for autophagosome formation.May control IL-1 alpha secretion.
SQSTM1p62, autophagy receptor, linked to HMGB1 secretion.Potential role in IL-1 alpha unconventional secretion.
NLRP3Inflammasome component, can regulate IL-1 family cytokines.Indirectly affects IL-1 alpha production.
CASP1Caspase-1, processes IL-1 family cytokines.May influence IL-1 alpha maturation.
GSDMDGasdermin D, mediates pyroptosis and IL-1 release.Potential role in IL-1 alpha secretion.
IL6Secondary cytokine induced by IL-1 alpha.Amplifies inflammatory responses.
CXCL8IL-8, induced by intracellular IL-1 alpha.Promotes cancer stemness and metastasis.

How Is positive regulation of interleukin-1 alpha production Regulated?

The positive regulation of IL-1 alpha production is controlled at multiple levels. Transcriptional regulation involves NF-kappaB and MAPK pathways activated by inflammatory stimuli. Post-transcriptional mechanisms, including mRNA stability and microRNA targeting, also modulate IL-1 alpha levels. Unconventional secretion via autophagy is regulated by ATG proteins and HMGB1. In cancer, intracellular IL-1 alpha signaling can inhibit mitophagy, altering cellular metabolism and promoting stemness. Additionally, paracrine factors such as IL-8 and GM-CSF can feedback to enhance IL-1 alpha production [3,8].

positive regulation of interleukin-1 alpha production and Human Disease

GeneDisease / BiologyPotential Experimental Model
IL1APsoriasis, hepatocellular carcinoma, leukemiaKeratinocyte knockout, monocyte overexpression [1,3]
HMGB1Psoriatic skin inflammationAutophagy-deficient keratinocyte models
IL8Hepatocellular carcinoma metastasisMonocyte-specific knockout or knockdown
CSF2Leukemia, bone marrow inflammationBone marrow cell knockout
SELEPancreatic carcinoma metastasisEndothelial cell knock-in of IL-1 alpha
Psoriasis and Skin Inflammation
In psoriasis, keratinocytes secrete HMGB1 via autophagy-based unconventional pathways, which plays a pivotal role in skin inflammation. This process is linked to increased IL-1 alpha production, contributing to the chronic inflammatory state characteristic of psoriatic lesions.
Hepatocellular Carcinoma
Intracellular IL-1 alpha in peritumoral monocytes induces IL8 production and inhibits mitophagy, promoting stemness and metastasis of hepatocellular carcinoma. This highlights the role of positive regulation of IL-1 alpha production in cancer progression and suggests potential therapeutic targets.
Leukemia and Hematological Malignancies
IL-1 alpha, along with TNF-alpha and interferon-alpha, affects the blast cells of acute myeloblastic leukemia, influencing cell proliferation and survival. IL-1 alpha also induces GM-CSF in immature normal bone marrow cells, linking inflammation to hematopoiesis.
Pancreatic Carcinoma Metastasis
Pancreas-carcinoma-derived IL-1 alpha induces E-selectin expression on endothelial cells, enhancing adhesion of carcinoma cells and promoting metastasis. This demonstrates how positive regulation of IL-1 alpha production can facilitate tumor dissemination.

From positive regulation of interleukin-1 alpha production-Related Genes to Experimental Models

Research QuestionSuitable Model
Does IL1A knockout reduce psoriatic inflammation?Keratinocyte-specific IL1A knockout mouse or human keratinocyte cell line
Does intracellular IL-1 alpha promote HCC stemness?Monocyte-specific IL1A overexpression in hepatocellular carcinoma models
What is the role of HMGB1 in IL-1 alpha secretion?HMGB1 knockout keratinocytes with autophagy induction
Can point mutations in IL1A alter its secretion?CRISPR knock-in of point mutations in IL1A in cell lines
Does IL-1 alpha paracrine signaling affect testis function?Testicular cell co-cultures with IL1A knockout
How does IL-1 alpha induce GM-CSF in bone marrow?Bone marrow cells with IL1R1 knockout

How to Study the positive regulation of interleukin-1 alpha production Process

MethodWhat It MeasuresTypical Application
RNA-seqTranscriptome-wide gene expressionIdentifying pathways that regulate IL1A transcription
ELISAIL-1 alpha protein concentrationQuantifying secreted and intracellular IL-1 alpha [1,3]
Western blotProtein levels and processingDetecting IL-1 alpha precursors and mature forms
ImmunofluorescenceCellular localization of IL-1 alphaVisualizing unconventional secretion
Autophagy flux assayLC3B turnoverAssessing autophagy involvement in IL-1 alpha secretion
CRISPR knockoutGene function lossTesting causal roles of candidate genes [1,3]
CRISPR knock-inPrecise mutations or tagsStudying point mutations or tagging IL-1 alpha
Co-culture assaysParacrine signalingMeasuring IL-1 alpha effects on target cells [5,7]
Transcriptional Profiling
RNA-seq and qPCR can measure IL1A mRNA levels in response to inflammatory stimuli, providing insights into transcriptional regulation of IL-1 alpha production [1,3].
Protein Detection and Secretion Assays
ELISA and Western blotting quantify IL-1 alpha protein levels in cell lysates and supernatants, distinguishing between intracellular and secreted forms [1,3].
Autophagy and Unconventional Secretion Analysis
LC3B puncta formation, ATG5/ATG7 knockdown, and HMGB1 secretion assays can dissect autophagy-based unconventional secretion of IL-1 alpha.
Functional Studies in Disease Models
Mouse models of psoriasis, hepatocellular carcinoma, and leukemia can be used to test the effects of modulating IL-1 alpha production on disease progression [1,3,6].

How CRISPR Can Be Used to Study GO:0032730 positive regulation of interleukin-1 alpha production

Knockout

CRISPR knockout of IL1A or upstream regulators (e.g., HMGB1, ATG5) can abolish IL-1 alpha production, confirming their essential roles in psoriatic inflammation and cancer progression [1,3].

Point Mutation

Introducing point mutations in IL1A or its regulatory elements can reveal critical residues or promoter sites required for positive regulation of IL-1 alpha production.

Knock-in

Knock-in of reporter tags (e.g., GFP) into the IL1A locus allows real-time tracking of IL-1 alpha expression and secretion in live cells.

Overexpression

Overexpression of IL1A or upstream activators (e.g., HMGB1) can drive excessive IL-1 alpha production, modeling inflammatory diseases and cancer [1,3].

How EDITGENE Supports positive regulation of interleukin-1 alpha production Research

Researchers studying positive regulation of interleukin-1 alpha production-related genes often need to determine whether a candidate gene is causally involved in IL-1 alpha synthesis, secretion, or signaling. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of interleukin-1 alpha production research.

Frequently Asked Questions About positive regulation of interleukin-1 alpha production

GO:0032730 is the Gene Ontology term for positive regulation of interleukin-1 alpha production, describing any process that activates or increases the frequency, rate, or extent of IL-1 alpha production.
Key genes include IL1A, HMGB1, ATG5, ATG7, IL1R1, IL8, CSF2, HGF, and SELE, among others [1,3,4,7,8].
IL-1 alpha is secreted via unconventional pathways, including autophagy-based secretion, as shown in keratinocytes.
Psoriasis, hepatocellular carcinoma, acute myeloblastic leukemia, and pancreatic carcinoma metastasis are linked to IL-1 alpha overproduction [1,3,6,7].
Intracellular IL-1 alpha in peritumoral monocytes induces IL8 and inhibits mitophagy, promoting stemness and metastasis in hepatocellular carcinoma.
CRISPR knockout, knock-in, and overexpression models allow precise manipulation of IL1A and its regulators to dissect causal roles in disease [1,3].
IL-1 alpha acts as a paracrine factor regulating Leydig cell function and steroidogenesis in the testis.
Yes, IL-1 alpha induces granulocyte-macrophage colony-stimulating factor (GM-CSF) in immature normal bone marrow cells.
IL-1 upregulates hepatocyte growth factor gene expression in human skin fibroblasts.
RNA-seq, ELISA, Western blot, immunofluorescence, autophagy flux assays, and CRISPR screens are commonly used [1,3].

Conclusion

GO:0032730, positive regulation of interleukin-1 alpha production, is a critical biological process that governs the synthesis and secretion of a master pro-inflammatory cytokine. Dysregulation of this process contributes to psoriasis, cancer progression, leukemia, and other inflammatory diseases [1,3,6,7]. Understanding the molecular mechanisms and key genes involved provides opportunities for therapeutic intervention. CRISPR-based models are indispensable for dissecting these pathways and identifying novel drug targets. EDITGENE offers a comprehensive suite of services to support research in this field, from knockout and knock-in models to library screening and bioinformatics.

References

  1. 1. Wang Z et al.. 2021. Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation.. Autophagy 17(2):529-552 PMID: 32019420
  2. 2. Ito A et al.. 1993. Regulation of hyaluronate production by interleukin 1 in cultured human chorionic cells.. Biochim Biophys Acta 1158(1):91-7 PMID: 8353136
  3. 3. Ruan YH et al.. 2025. Intracellular IL1α in Peritumoral Monocytes Induces IL8 Production and Inhibits Mitophagy to Promote Stemness and Metastasis of Hepatocellular Carcinoma.. Cancer Res 85(21):4164-4181 PMID: 40857615
  4. 4. Matsumoto K et al.. 1992. Up-regulation of hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts.. Biochem Biophys Res Commun 188(1):235-43 PMID: 1384479
  5. 5. Svechnikov K et al.. 2004. The paracrine role played by interleukin-1 alpha in the testis.. Curr Drug Targets Immune Endocr Metabol Disord 4(1):67-74 PMID: 15032628
  6. 6. Carter A et al.. 1992. Effect of interleukin-1, tumor necrosis factor-alpha, and interferon-alpha on the blast cells of acute myeloblastic leukemia.. Am J Hematol 40(4):245-51 PMID: 1503080
  7. 7. Kaji M et al.. 1995. E-selectin expression induced by pancreas-carcinoma-derived interleukin-1 alpha results in enhanced adhesion of pancreas-carcinoma cells to endothelial cells.. Int J Cancer 60(5):712-7 PMID: 7532161
  8. 8. Bot FJ et al.. 1990. Interleukin-1 alpha also induces granulocyte-macrophage colony-stimulating factor in immature normal bone marrow cells.. Blood 76(2):307-11 PMID: 1695108
Contact Us
*
*
*
*
How did you hear about us: